CAFC Affirms PTAB Obviousness Ruling for Fluid-Mixing Patent

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision today in Medmix Switzerland AG v. Squires, affirming a Patent Trial and Appeal Board (PTAB) final written decision that found several claims of a Medmix fluid-mixing patent unpatentable as obvious. The decision upholds the Board’s construction of a disputed claim term and its finding that a skilled artisan would have been motivated to combine the prior art references at issue.

Medmix Switzerland AG owns U.S. Patent 9,010,578, which is directed to an arrangement for mixing and discharging fluids. The design includes a cartridge with at least two chambers, an accessory part that serves as a mixer, and a connecting device that links the two components. The connecting device includes complementary engagement parts, referred to in the patent as guide grooves attached to the cartridge and ramps attached to the mixer. According to the patent, rotating these parts into and out of engagement securely attaches and later detaches the cartridge and mixer with minimal force.

Xinial Systems GmbH & Co. KG petitioned for inter partes review (IPR) of claims 1 through 3, 9 through 13, and 16 through 17 of the ‘578 patent, arguing the claims would have been obvious over the U.S. Patent 6,769,574 (Keller) and U.S. Patent 6,161,730 (Heusser), each in combination with Canadian Patent 1,238,023 (Yu). Keller ‘574 and Heusser both disclose dual-chamber cartridges attached to mixers, while Yu discloses a caulking gun with a removable nozzle connected through a curved coarse thread design. Xinial contended that a skilled artisan would have been motivated to incorporate Yu’s coarse thread connection into the designs disclosed by Keller ‘574 and Heusser.

The parties disputed the meaning of “‘at least two ramps,’ recited in all challenged claims.” Medmix argued the term should be limited to ramps shaped as an inclined plane, while Xinial argued no particular shape was required. The Board sided with Xinial, adopting the plain and ordinary meaning of the term, and went on to find that Xinial had established a motivation to combine the references, rendering all challenged claims unpatentable.

On appeal, Medmix challenged the Board’s construction of “at least two ramps,” arguing it should have been limited to an inclined-plane shape. Additionally, Medmix argued that the Board’s motivation for combining findings lacked substantial evidentiary support. Since Medmix did not argue the claims separately, the CAFC addressed them as a group.

Moreover, the CAFC reviewed the claim construction question de novo and found that nothing in the claim language requires the ramps to have any particular shape. The court noted that the specification likewise described the “guide grooves” only in general terms, stating that their shape corresponds substantially to that of the ramps, without specifying any particular configuration for either. The opinion cited Phillips v. AWH Corp., and stated that “the claims of a patent define the invention.”

Medmix pointed to Figures 1 and 4 of the patent, which depict ramps shaped as inclined planes, as well as specification language describing a separate component, the socket jaw, “likewise designed…as an inclined plane.” The CAFC rejected this argument, explaining “it is improper to read limitations from a preferred embodiment described in the specification…into the claims absent a clear indication in the intrinsic record that the patentee intended the claims to be so limited.” The court noted that the specification expressly characterized its figures as “preferred illustrative embodiments” not meant to constrain claim scope.

Medmix also raised an argument based on the prosecution history of the ‘578 patent. During prosecution, the original claim language reciting “connecting components” was rejected under the U.S. Patent 5,033,650 (Colin), which lacked ramps shaped as inclined planes. The applicant then amended the claim to recite “engagement parts” comprising guide grooves and ramps. Medmix argued this amendment was intended to narrow the claims to a specific ramp shape. The CAFC disagreed, finding the amendment was made to distinguish Colin on the basis that it failed to disclose engagement parts capable of providing axial guidance during both attachment and release, not because of any particular shape requirement. The court thus affirmed the Board’s claim construction and noted that Medmix did not dispute that Yu discloses ramps under that construction.

The CAFC then turned to the motivation-to-combine issue. The Board had found that incorporating Yu’s coarse-thread design into Keller ‘574 and Heusser would provide “mechanical advantage.” It explained that this would reduce the axial force needed to detach the cartridge and mixer in the Keller ’574-Yu combination and reduce the rotations required in the Heusser-Yu combination.

Medmix argued, relying on Henny Penny Corp. v. Frymaster LLC, that the Board failed to weigh the disadvantages of the proposed combinations, specifically the risk that backpressure during dispensing would cause the coarse-thread connection to separate and leak. The CAFC distinguished Henny Penny, explaining that the Board had found a skilled artisan could “easily” address any leakage concerns by adding tangs and flanges to reinforce the connection between the cartridge and mixer, a finding supported by expert testimony in the record. Since the proposed combination did not present the decreased efficiency at issue in Henny Penny, the CAFC held that the Board’s motivation to combine findings were supported by substantial evidence.

Ultimately, the CAFC rejected both of Medmix’s arguments and affirmed the Board’s determination that the challenged claims of the ‘578 patent are unpatentable as obvious.

Image Source: Deposit Photos
Image ID:103763568
Copyright:bigfatnapoleon